Integrins form the major family of proteins that mediates cell-matrix interactions. As well as an adhesive function, it is increasingly apparent that integrins can transduce messages via classic signalling pathways and impact upon such fundamental cellular processes as proliferation, apoptosis, diVerentiation, and motility. Dysegulation of these processes are a feature of many malignancies. Altered integrin expression has been observed in many human tumours, and perturbation of integrin function or expression in experimental systems has demonstrated that altered integrin signalling may directly contribute to the development of the malignant phenotype. (J Clin Pathol: Mol Pathol 1999;52:208-213) 
Cell-matrix interactions directly participate in the control of cellular diVerentiation, morphogenesis, proliferation, and migration, and thereby impact on such processes as embryogenesis, wound healing, inflammation, and cancer. Many of these interactions with the extracellular matrix are mediated by the integrin family of cell adhesion molecules. In addition to their adhesive function, integrins are now recognised as signalling molecules capable of transducing messages via classic signalling pathways, and integrin receptor function can be regarded as a key modulator of cellular behaviour. The aim of this review is to outline what is currently understood about the structural basis of integrin signalling, the role of integrins in modulating normal cell processes, and the potential contribution of altered integrin function in development of the malignant phenotype.
Structural features of integrins
The integrins form a family of heterodimeric cell surface receptors composed of noncovalently linked dissimilar and subunits. 1 To date ,15 and eight subunits have been described and these combine to form over 20 diVerent receptors (table 1) . 1 Most integrins function as receptors for extracellular matrix (ECM) proteins; however, some family members, such as the 2 integrins, and 4 1 integrin, mediate heterotypic cell-cell adhesion. The a/ associations determine the ligand binding specificities of the receptor for various extracellular matrix proteins. Although some integrins, such as the fibronectin receptor 5 1, recognise only a single ligand, more commonly an integrin is capable of binding several ligands.
2 There is further functional overlap in that several integrins may bind to the same matrix protein-for example, there are at least seven diVerent receptors for fibronectin. In some cases the integrins bind to diVerent regions of the ligand, as do the 4 1 and 5 1 receptors, 3 whereas in other cases the integrins bind to the same region of the protein-for example, the binding of 5 1 and 3 1 to fibronectin. 4 This apparant redundancy in the system suggests that integrins function as more than mere sticky molecules, and it is likely that interactions between specific receptors and distinct ligand binding sites can communicate unique information to cells.
Integrins are well adapted for the transmission of information from the extracellular environment into the cell. The cytoplasmic domains of both subunits of the integrin receptors interact with the cytoskeleton (fig 1) . With the exception of the 4 subunit, the chain cytoplasmic domains are relatively short, being composed of between 40 and 60 amino acids. They are highly conserved and they interact with the actin cytoskeleton via a range of cytoskeletal proteins such as -actinin, talin, vinculin, and tensin in the formation of focal adhesions. 5 The 4 subunit has a large cytoplasmic domain (> 1000 amino acids long), which interacts with the intermediate filament cytoskeleton rather than the actin cytoskeleton. 6 This integrin is a major component of hemidesmosomes-stable adhesive structures found in the basal cell layer of stratified and complex epithelia-and it has been shown recently that the cytoplasmic domain of 4 integrin is essential for the formation of hemidesmosomes. 7 From this diversity of receptor structure it is evident that a range of cellular responses could be initiated through binding of a single ligand.
Integrin signalling mechanisms
Integrins can mediate signalling by two mechanisms, so called "inside out" signalling and "outside in" signalling ( fig 2) . 8 9 Inside out signalling is the mechanism by which a cell regulates the aYnity state of its integrin receptors. 8 It is thought to involve the propagation of conformational changes from the cytoplasmic domains of integrins to the extracellular binding site in response to intracellular signalling events. 10 Several regions within the cytoplasmic domains of both and subunits have been shown to be involved in regulating the aYnity state of the integrin receptor. There is evidence that conformational changes within these regions, brought about through phosphorylation or dephosphorylation events, allow the association of other proteins that can regulate the integrin activity state. 11 12 Outside in signalling mediates signals from the extracellular matrix after integrin ligation and involves regulation of many fundamental cellular processes. 8 It involves integrin-ligand binding and receptor clustering, with subsequent assembly of the focal adhesion plaque-a complex of cytoskeletal proteins and signalling molecules including paxillin, talin, vinculin, -actinin, tensin, and focal adhesion kinase (FAK). 6 This process is dependent on the GTPase Rho A. 13 14 Phosphorylated FAK can also lead to activation of the mitogen activated protein (MAP) kinase pathway, probably via Ras activation, which can then influence gene expression. 15 16 Integrin control of cell function PROLIFERATION One of the defining characteristics of normal cells is that they require anchorage to a substratum to proliferate. 17 Although normal cells require mitogenic growth factors to proliferate, it is the coordinate response of a cell to both growth factors and integrin mediated signals that regulates the progression through the cell cycle (fig 3) . 18 A key event in the progression through the G1 phase of the cell cycle is hyperphosphorylation of the retinoblastoma protein (Rb). In quiescent cells, hypophosphorylated Rb exists as a complex bound to the E2F family of transcription factors; phosphorylation of Rb leads to release of E2F, which can then bind to E2F responsive elements, leading to transcription of several growth regulatory genes, including cyclin A. [19] [20] [21] The phosphorylation status of Rb is regulated by cyclins, which in turn are regulated by mitogenic growth factors, either by induction of cyclin proteins or by repression of the cyclin dependent kinase (cdk) inhibitory proteins p21 and p27. 20 22 It has been shown that mitogen induced progression through the G1 phase is dependent on cellular interaction with the extracellular matrix; both the induction of cyclin D1 mRNA and protein, and the reduction of cdk inhibitory proteins is minimal in the absence of cell attachment to a substratum. 23 24 This control of the cell cycle appears to be mediated via integrin induced reorganisation of the cytoskeleton. 25 26 
APOPTOSIS
As well as controlling progression through the cell cycle, integrin mediated cell anchorage plays a central role in the control of apoptosis. 26 The term "anoikis" has been coined to describe the apoptosis that occurs when cells are detached from their matrix. Integrins that can activate tyrosine phosphorylation of the adaptor protein Shc and activate the Ras-ERK (extracellular signal related protein) signalling pathway, such as 1 1, 5 1, and v 3, may protect cells from undergoing apoptosis, whereas integrins that are not linked to Shc appear to induce apoptosis. 27 Integrin mediated activation of FAK and subsequent activation of MAP kinases has been implicated in some cell systems as a mechanism of control of apoptosis. Expression of an activated form of FAK in MDCK (Madin-Darby canine kidney) epithelial cells blocks anoikis, 28 and microinjection of peptides leading to inactivation of FAK, or inhibition of FAK by antisense oligonucleotides, triggers apoptosis in fibroblasts 29 and rhabdomyosarcoma tumour cells, 30 respectively. The precise pathways are not yet established, but FAK may act via phosphatidylinositol 3-kinase (PI-3K) to activate the anti-apoptotic protein Bcl-2. 31 32 In contrast to these anti-apoptotic signals via integrins, the 6 4 integrin has been shown to induce apoptosis in a rectal cancer cell line with concomitant upregulation of the cdk inhibitor p21. 33 
Figure 3 Influence of integrin mediated signalling on cell cycle progression. Both integrin-ligand binding and growth factors are required to induce cyclin D1 and repress the cyclin dependent kinase (cdk) inhibitory proteins p21 and p27. Active cyclin D1-cdk4/6 and cyclin E-cdk2 phosphorylate the Rb protein, releasing E2F, which induces expression of cyclin A. Integrin-ligand binding is also required for growth factor independent cyclin A induction. Cyclin

DIFFERENTIATION
It is well established that cell-matrix interactions play a crucial role in the development of the diVerentiated phenotype. In the mouse mammary gland, 1 integrin mediated interactions with the extracellular matrix induce synthesis of the milk protein -casein. 34 In human mammary epithelial cell lines, 2 1 integrin modulates epithelial diVerentiation and glandular morphogenesis, 35 and gland formation by colorectal epithelial cells is also 1 integrin dependent. 36 Analysis of knockout mice has indicated a key role for 6 4 integrin in establishing epithelial cell polarity in basal keratinocytes. 37 Together, these studies indicate that the characteristics of a cell are largely defined by its expression profile of integrin receptors.
Integrins and cancer
Many of the processes in which integrins appear to play a central role-anchorage dependent growth, apoptosis, diVerentiation, and migration-are precisely those that are characteristically dysregulated in malignancy. Therefore, it is not surprising that much attention has focused on the potential involvement of altered integrin expression in cancer.
Many malignancies exhibit altered expression of integrin receptors in comparison with their normal counterparts. [38] [39] [40] [41] [42] [43] The most clear cut association between an altered integrin profile and tumour progression has been demonstrated for malignant melanoma. The collagen receptor 2 1 is more strongly expressed in invasive melanoma compared with in situ melanoma, 44 and this reflects in vitro studies, where 2 1 expression is associated with enhanced invasion of melanoma cell lines, 45 46 and there is consistent, strong correlation between acquisition of v 3 integrin and both the vertical growth phase of melanoma and metastasis. 47 Integrin receptor expression can alter tumour cell growth rate. Transfection of Chinese hampster ovary cells with 5 1 inhibits anchorage independent growth, reduces proliferation, and leads to a non-tumorigenic phenotype when injected into nude mice. 48 In addition, expression of 5 1 in HT29 colon cancer cells significantly inhibits proliferation. 49 By contrast, some integrins appear to regulate proliferation positively. Melanoma cells selected for lack of the v 3 integrin have significantly reduced proliferation and tumorigenicity, which is reversed by re-expression of the integrin. 50 Resistance to apoptosis is a feature of many malignant cells and such resistance may be the result of aberrant integrin signalling-for example, in rhabdomyosarcoma, downregulation of integrin associated FAK induces apoptosis in these cells, 30 whereas MDCK cells that overexpress FAK are rescued from apoptosis and become anchorage independent and tumorigenic. 28 It has been suggested that altered cell-matrix interactions could play a role in the initiation of malignancy by dysregulating pathways that control genomic stability. 51 Recent studies indicate that cell-matrix interactions can control p53 activity and that in the absence of matrix attachment p53 concentrations are reduced. 52 When fibroblasts are exposed to irradiation they exhibit p53 mediated cell cycle arrest. If the cells are released from the substratum they do not show raised p53 concentrations or cell cycle arrest. 53 This implies that loss of integrin mediated adhesion may predispose cells to the generation of mutations and potentially neoplastic transformation.
Integrins also contribute to cellular migration and metastasis-for example, transfection of melanoma cells with 3 integrin promotes cell migration and metastasis, 54 and migration and invasion of glioma cells is specifically inhibited by antibodies to 3 1 integrin. 55 Our laboratory has shown that upregulation of 6 4 integrin in a breast cancer cell line and redistribution of this integrin to discrete adhesive structures is associated with a significant reduction in invasive behaviour. 56 One way in which integrins may control the invasive phenotype is through crosstalk with other cell adhesion molecules. The integrin linked kinase (ILK) binds to the cytoplasmic domains of 1 and 3 integrins, and is activated by integrinligand interactions. 57 Overproduction of a constitutively active ILK in both intestinal and mammary epithelial cells leads to downregulation of the invasive suppressor protein E-cadherin, and acquisition of an invasive phenotype. 58 Another important aspect of invasion is proteolytic remodelling of the stroma by enzymes such as the matrix metalloproteinases (MMPs). In rabbit synovial fibroblasts, 4 1 and 5 1 integrins diVerentially regulate the production of MMPs. 59 60 Tumour cells frequently display an altered integrin repertoire compared with their normal counterparts, and this may be a mechanism whereby cells can control the synthesis and secretion of proteolytic enzymes. In human melanoma cell lines, the diVerential expression of 5 1 integrin and v 3 integrin modulates release of MMP-2 and subsequent invasive behaviour, 61 and in colon cancer cells, v 6 integrin mediated signalling controls release of the gelatinase enzyme MMP-9. 62 A physical relation between integrin receptors and proteolytic enzyme systems has also been described between the v 3 integrin and MMP-2, 63 which appears to provide migratory cells with coordinated matrix degradation and motility.
Summary
The integrin family of receptors forms a diverse group of molecules, which through their interactions with diVerent matrix molecules and with diVerent cytoskeletal elements can generate a wide range of cellular responses. It is now evident that integrin mediated signalling can influence proliferation, apoptosis, diVerentiation, and migration, and their involvement in such fundamental processes suggests that altered function or expression of integrins by a cell may influence the development of the malignant phenotype (fig 4) . 
